Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
1996 |
| gptkbp:ATCCode |
gptkb:R06AX26
|
| gptkbp:availableOn |
gptkb:tablet
Oral suspension Orally disintegrating tablet |
| gptkbp:contraindication |
Hypersensitivity to fexofenadine
|
| gptkbp:drugClass |
gptkb:Antihistamine
|
| gptkbp:excretion |
Urine
Feces |
| gptkbp:genericName |
gptkb:Fexofenadine
|
| gptkbp:halfLife |
14 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Allegra
|
| gptkbp:interactsWith |
Antacids containing aluminum or magnesium
Fruit juices |
| gptkbp:legalStatus |
OTC in US
Prescription in some countries |
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:metabolism |
Minimal hepatic metabolism
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
Over-the-counter
|
| gptkbp:routeOfAdministration |
gptkb:Oral
|
| gptkbp:sideEffect |
gptkb:Nausea
Dizziness Headache Drowsiness |
| gptkbp:usedFor |
gptkb:Chronic_idiopathic_urticaria
Allergic rhinitis |
| gptkbp:bfsParent |
gptkb:Sanofi-Aventis
|
| gptkbp:bfsLayer |
6
|